Human Immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1 + NK cells in ugandans carrying the HLA-B Bw4 motif

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 4802-4811

  Eller, Michael A ^a,b,c   Koehler, Rebecca N ^c   Kijak, Gustavo H ^c   Eller, Leigh Anne ^b,c   Guwatudde, David ^b,d   Marovich, Mary A ^c   Michael, Nelson L ^c   de Souza, Mark S ^c,e   Wabwire Mangen, Fred ^b,d   Robb, Merlin L ^c   Currier, Jeffrey R ^c   Sandberg, Johan K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAKERERE UNIVERSITY   (Uganda)

^c US Military HIV Research Program   (United States)

^d MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^e ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA B BW4 ANTIGEN; HLA C ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2 GENE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3 GENE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1 GENE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1 GENE; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; RURAL POPULATION; UGANDA; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIGENS, CD56; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MIDDLE AGED; RECEPTORS, KIR3DL1; UGANDA; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79955416554     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00111-11     Document Type: Article

References (51)

1. Alter, G., et al. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204: 3027-3036.
2. + NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 83:6798-6805.
3. Andersson, S., C. Fauriat, J. A. Malmberg, H. G. Ljunggren, and K. J. Malmberg. 2009. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 114:95-104.
4. Bandyopadhyay, S., et al. 1990. Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1. Clin. Exp. Immunol. 79:430-435.
5. Barbour, J. D., et al. 2007. Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 3:e43.
6. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991.
7. Bonaparte, M. I., and E. Barker. 2004. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104:2087-2094.
8. Boulet, S., et al. 2008. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 22:1487-1491.
9. Boulet, S., et al. 2010. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J. Immunol. 184:2057-2064.
10. Cao, K., et al. 2004. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 63:293-325.
11. Carr, W. H., M. J. Pando, and P. Parham. 2005. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175:5222-5229.
12. Carrington, M., M. P. Martin, and J. van Bergen. 2008. KIR-HLA intercourse in HIV disease. Trends Microbiol. 16:620-627.
13. Carrington, M., and S. J. O'Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54:535-551.
14. Cohen, G. B., et al. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661-671.
15. Dokun, A. O., et al. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:951-956.
16. Eller, L. A., et al. 2007. Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence Ugandan blood bank population. J. Clin. Microbiol. 45:3281-3285.
17. Eller, M. A., et al. 2009. Elevated NK cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection. J. Acquir. Immune Defic. Syndr. 51:380-389.
18. Fauci, A. S., D. Mavilio, and S. Kottilil. 2005. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat. Rev. Immunol. 5:835-843.
19. Fehniger, T. A., et al. 1998. Natural killer cells from HIV-1 + patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161:6433-6438.
20. Flores-Villanueva, P. O., et al. 2001. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. U. S. A. 98:5140-5145.
21. + T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 4:e1000101.
22. Freel, S. A., et al. 2010. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. J. Virol. 84:4998-5006.
23. Gardiner, C. M., et al. 2001. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J. Immunol. 166:2992-3001.
24. Gaudieri, S., et al. 2005. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 6:683-690.
25. Gonzalez, V. D., et al. 2008. Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets. J. Immunol. Methods 330:64-74.
26. Guwatudde, D., et al. 2009. Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, Uganda. PLoS One 4:e4145.
27. Iannello, A., O. Debbeche, S. Samarani, and A. Ahmad. 2008. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J. Leukoc. Biol. 84:1-26.
28. Karre, K. 2008. Natural killer cell recognition of missing self. Nat. Immunol. 9:477-480.
29. Kijak, G. H., et al. 2009. HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster. Tissue Antigens 73:262-269.
30. Koehler, R. N., et al. 2009. High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1 and their HLA class I ligands using real-time PCR. Tissue Antigens 74:73-80.
31. Kottilil, S., et al. 2003. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis. 187:1038-1045.
32. Le Gall, S., et al. 1998. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8:483-495.
33. Li, H., V. Pascal, M. P. Martin, M. Carrington, and S. K. Anderson. 2008. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet. 4:e1000254.
34. Lopez-Vazquez, A., et al. 2005. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum. Immunol. 66:285-289.
35. Marsh, S. G., et al. 2002. Nomenclature for factors of the HLA system, 2002. Tissue Antigens 60:407-464.
36. Martin, M. P., et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434.
37. Martin, M. P., et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740.
38. Norman, P. J., et al. 2007. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat. Genet. 39:1092-1099.
39. Olemukan, R. E., et al. 2010. Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting. Clin. Vaccine Immunol. 17:910-918.
40. Oliva, A., et al. 1998. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102:223-231.
41. Parsons, M. S., et al. 2010. Mind the gap: lack of association between KIR3DL1*004/HLA-Bw4-induced natural killer cell function and protection from HIV infection. J. Infect. Dis. 202(Suppl. 3):S356-S360.
42. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
43. Single, R. M., et al. 2007. Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 39:1114-1119.
44. Sun, J. C. 2010. Re-educating natural killer cells. J. Exp. Med. 207:2049- 2052.
45. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457:557-561.
46. Taner, S. B., et al. 2010. Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J. Immunol. 186:62-72.
47. Thomas, R., et al. 2008. Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J. Immunol. 180:6743-6750.
48. Tiemessen, C. T., et al. 2010. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J. Infect. Dis. 202:1444-1453.
49. Wong, A. H., et al. 2010. Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. AIDS Res. Hum. Retroviruses 26:459-469.
50. Yawata, M., et al. 2006. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203:633-645.
51. Yokoyama, W. M. 2005. Specific and nonspecific natural killer cell responses to viral infection. Adv. Exp. Med. Biol. 560:57-61.